Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 15, 2016 and accepted by EDGAR at Aug 15, 2016, 12:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$12.0kus-gaap:Revenues
Revenue6 months2016-01-01 to 2016-06-30$18.0kus-gaap:Revenues
Research and development3 months2016-04-01 to 2016-06-30$6.4mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2016-01-01 to 2016-06-30$11.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-04-01 to 2016-06-30$28.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2016-01-01 to 2016-06-30$55.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-04-01 to 2016-06-30−$35.0mus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$66.6mus-gaap:OperatingIncomeLoss
Income tax3 months2016-04-01 to 2016-06-30−$228.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-01-01 to 2016-06-30−$371.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-04-01 to 2016-06-30−$34.0mus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$64.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30−$0.41us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30−$0.79us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2016-01-01 to 2016-06-30−$17.2mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2016-01-01 to 2016-06-30$2.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2016-01-01 to 2016-06-30$9.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-06-30$38.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-06-30$218.0mus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$342.9mus-gaap:Assets
Current liabilitiesAt period end2016-06-30$10.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$15.6mus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30$327.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-16-024275. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.